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Abstract 
The effect of neuroticism on health has been debated throughout health research. Many 
studies indicate negative effects of neuroticism finding it to be related to risky health 
behaviours, worse self-rated health, somatic complaints and higher mortality. However, there 
has been the proposal of healthy neuroticism in that when combined with vigilance or 
conscientiousness, neuroticism may result in better health. The present research recruited two 
samples; a New Zealand sample (N = 336) and a United States sample (N = 199), to complete 
an online survey about their personality, health status and a body vigilance questionnaire, 
including two vigilance factors, sensation awareness belief and change awareness belief. 
Mediation, moderation and moderated mediation analyses were conducted for both samples. 
The New Zealand sample found one mediation effect which suggested that higher 
neuroticism is related to higher sensation awareness belief, which in turn is related to poorer 
physical health and one significant moderation effect where conscientiousness moderated the 
relationship between neuroticism and mental health. The United States sample found two 
mediation effects which suggested that higher neuroticism is related to higher sensation 
awareness belief, which in turn is related to poorer mental health and poorer sleep and one 
significant moderation effect where conscientiousness moderated the relationship between 
neuroticism and physical health. No significant moderated mediation effects were found for 
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The Relationship Between Neuroticism and Health Outcomes: The Effects of Vigilance 
and Conscientiousness 
Neuroticism is one of the “Big Five” personality traits. It is typically defined by 
negative attitude in response to threat or frustration (Lahey, 2009). There is debate in the 
literature regarding the relationship between neuroticism and health. There are many studies 
that have focussed on the negative effects of neuroticism stating that those high in 
neuroticism, are more likely to participate in risky behaviour, have higher body mass indexes, 
report more somatic symptoms and chronic diseases and greater mortality (Lahey, 2009; 
Mroczek, Spiro & Turiano, 2009; Weston & Jackson, 2018).  There is also discussion of the 
idea of healthy neuroticism suggesting that neuroticism coupled with high levels of 
conscientiousness or vigilance may result in better health outcomes (Weston & Jackson, 
2018; Brickman, Yount, Blaney, Rothberg & De-Nour, 1996; Sutin et al., 2010). The present 
research further examines the relationship between neuroticism and health outcomes.  
The Definition of Neuroticism 
There is some debate over the definition of neuroticism but general agreement is that 
it mainly involves negative affect. It is also often categorised by irritability, anger, worry, 
sadness and vulnerability (Lahey, 2009).  While some interpret neuroticism to emphasize 
negative affect, others focus more on the psychological aspects such as worry and 
rumination. Others may stress the importance of aspects such as psychophysiological stress 
and anxiety, while others focus on behavioural aspects such as recklessness and hostility 
(Friedman, 2019). Neuroticism has also been referred to as “emotional instability” (Najjab, 
Palka, & Brown, 2020). Individuals who are referred to as “emotionally stable” are often low 
in neuroticism and those high in neuroticism, are more likely to experience daily emotional 
stress and react more strongly to events (Weston & Jackson, 2018).  Highly neurotic 
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individuals tend to feel, notice and report more symptoms and pain and experience 
more health-related anxiety (Anagnostopoulos & Botse, 2016). It has been found that 
those high in neuroticism report more somatic complaints and react to them more 
dramatically as they interpret them as threats to their health (Friedman, 2019). 
Eysenck and Eysenck (1975) originally described those highly neurotic as “worriers” 
whose main characteristic was constant worrying about things that may go wrong and strong 
emotional responses of anxiety to these thoughts. Neurotics also tend to be self-critical, 
sensitive to criticism and can feel inadequate. Whereas people with low neuroticism, tend to 
have a mild and slow emotional response (Liu & Lin, 2019).  Neuroticism tends to peak in 
late adolescence and decline slightly during adulthood (Lahey, 2009). Due to neuroticism’s 
definition it has been found to have a complicated relationship with health, studies have 
found both negative and positive effects of neuroticism.    
The Negative Effects of Neuroticism 
There have been many studies investigating the negative effects of neuroticism. 
Neuroticism has been linked to worse physical health outcomes (e.g. greater asthma 
diagnoses and mortality), worse self-reported health, poorer health outcomes when self-report 
measures are used and greater use of health services (Kitayama et al, 2018; Najjab et al., 
2020; Shipley, Weiss, Der, Taylor & Deary, 2007; ten Have, Oldehinkel, Vollebergh & 
Ormel, 2005).  It has been linked to several physical health problems such as cardiovascular 
diseases, eczema, asthma and irritable bowel syndrome as well an increased number of 
somatic complaints and increased mortality (Lahey, 2009).  Neuroticism has also been linked 
to health risk behaviours (e.g. alcohol consumption, drug use, sedentary lifestyles, unhealthy 
eating) which in turn results in worse health outcomes (Mroczek et al., 2009; Vollrath & 
Torgersen, 2002).  High neuroticism has been related to poor sleep quality and increased 
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daytime sleepiness (Duggan, Friedman, McDevitt & Mednick, 2014). It has also been 
suggested that there may be a mediation link between neuroticism and health outcomes. For 
example, Liu and Lin (2019) found practicing meditation to be a mediator between 
neuroticism and health outcomes. Ploubidis and Grundy (2009) found the effect of 
neuroticism on health to be largely mediated by psychological distress and physical health.   
One study examined the relationship between neuroticism and the prevalence of 
asthma. The study looked at all “Big Five” personality traits and a lifetime asthma diagnosis. 
Personality was measured at one point whereas asthma was recorded at three points across 54 
years. The study followed a random sample of 10,317 individuals starting in 1957 with data 
collected in 1975, 1992, 2004 and 2011. Personality was measured using the 54-item Big 
Five Inventory in 1992 whereas asthma was measured using self-report in 1992, 2003 and 
2011. Ultimately the study found that higher neuroticism scores were related to a greater risk 
of a lifetime asthma diagnosis (Najjab et al., 2020).  
 There has been suggestion that perhaps neuroticism leads to greater health risk 
behaviours such as excessive drinking which in turn, results in poorer physical health 
(Mroczek et al., 2009; Vollrath & Torgersen, 2002).  A 21-year prospective cohort study 
conducted in Britain on 5424 adult individuals suggested that the relationship between 
neuroticism and health outcomes may be mediated by health risk behaviours. They found that 
neuroticism was related to higher mortality. However, when controlled for social class, 
education, smoking, alcohol consumption, physical activity and overall health, neuroticism 
was not related to mortality except for cardiovascular disease (Shipley et al., 2007). Perhaps 
mortality was due to other risk factors (such as smoking, alcohol, lesser health etc.) rather 
than neuroticism. However, it is also possible that socio-economic factors (such as class or 
education) may lead to health risk behaviours that in turn result in worse health, rather than 
neuroticism causing these risky behaviours (Shipley et al., 2007).  
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Another longitudinal study conducted a survival analysis using measures of 
neuroticism made in 1975 to predict mortality over 30 years in a group of older men, looked 
at risky behaviours, namely smoking and drinking behaviours and their relationship to 
neuroticism and mortality. The authors concluded that smoking explains 40% of the 
relationship between neuroticism and mortality, leaving a large amount unexplained 
suggesting that neuroticism may affect health in other ways than simply through risky health 
behaviour. However, they did not find drinking behaviours to be associated with mortality 
(Mroczek et al., 2009). A different study which used 683 university students as participants 
looked at health risk behaviours such as smoking, alcohol consumption, drug consumption 
and risky sexual behaviour and their relationship with high neuroticism. They found that 
those high in neuroticism were more likely to partake in multiple, risky behaviours and 
concluded neuroticism to have a negative impact on health (Vollrath & Torgersen, 2002). 
Neuroticism has been related to both poor physical and mental health. A study 
examining changes in personality and health over a four-year period found that increases in 
neuroticism were related to poorer health. Participants were 11,105 adults with personality 
and health measures being recorded at baseline and the four year follow up. The follow up 
found that increasing neuroticism resulted in both poorer mental health and physical health 
(Magee, Heaven & Miller, 2013).  Another longitudinal study looked at neuroticism in youth 
and its follow-up 40 years later. This study found that the impact of neuroticism on wellbeing 
was largely indirect through psychological and physical health issues (Gale, Booth, Mõttus, 
Kuh & Deary, 2013).  
Neuroticism has also been negatively associated with mental health conditions, 
namely anxiety and depressive disorders (Liu & Lin, 2019). It has been proposed that this 
may be due to the crossover of symptoms such as worry and sadness (Lahey, 2009). A meta-
analysis found considerable effect sizes with neuroticism to mental disorders including mood 
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disorders (d = 1.54), somatoform disorders (d = 1.20), anxiety disorders (d = 1.04) and eating 
disorders (d = 1.29) (Malouff, Thorsteinsson and Schutte, 2005). A separate meta-analysis 
has found that neuroticism is highly correlated with mental health symptoms. This looked at 
the role of meditation and optimism as a mediator between neuroticism and depression and 
neuroticism and anxiety. They found that neuroticism was directly related to anxiety and 
depression, as well as practicing meditation having a mediating role (Liu & Lin, 2019).  A 
separate mediation study found that neuroticism had an indirect effect on causes of mortality 
(somatic health, smoking, alcohol and psychological distress) and higher neuroticism being 
associated with a greater mortality risk. They found that the effect of neuroticism on 
mortality was largely mediated by psychological distress and somatic health (Ploubidis & 
Grundy, 2009). 
Following the idea that neuroticism is related to poorer mental health, one study has 
found significant correlations between worry and neuroticism and that neuroticism was more 
related to anxiety than depression (Muris, Roelofs, Rassin, Franken & Mayer, 2005). While, 
Cervera et al., 2003 found neuroticism showed an increased risk in developing an eating 
disorder. It has also been found that individuals with schizophrenia scored higher on implicit 
neuroticism than the healthy controls (Suslow, Lindner, Kugel, Egloff & Schmukle, 2014).  
Another nine year follow up study examined 206 depressed elderly participants. The study 
looked at recovery from depression after nine years and found that low neuroticism was a 
predicator of recovery (Steunenberg et al., 2007). 
Ultimately, many studies have repeatedly found negative effects of neuroticism. 
Neuroticism has been linked to a number of physical and mental conditions that result in 
worsened health outcomes (for example, greater mortality, slower recovery, greater 
prevalence of anxiety and depressive disorders). Many studies are quick to conclude that 
neuroticism itself results in poorer health outcomes, however, others propose that perhaps the 
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effects of neuroticism are indirect, such as the impact of neuroticism on wellbeing being 
largely indirect via psychological and physical health issues (Gale et al., 2013) or that 
neuroticism itself results in more risky health behaviours and those behaviours result in the 
worsened health (Vollrath & Torgersen, 2002). It has also been suggested that physiological 
factors may have a greater impact on one’s health e.g. stress hormones and cholesterol have 
an impact on glucose levels and other factors of one’s metabolism which is affected by what, 
when and how much someone eats and drinks (Friedman, 2019). The findings that support 
the idea of neuroticism resulting in poor health are significant, however the concept of 
healthy neuroticism has also been found in many studies.  
Healthy Neuroticism 
It is important to note that not all studies find negative outcomes or find very small 
effects of neuroticism. For example, there are studies that find no relationship between 
neuroticism and mortality (e.g., Huppert & Whittington, 1995; Iwasa et al., 2008) or between 
neuroticism and health behaviours (e.g., Atherton, Robins, Rentfrow & Lamb, 2014). Perhaps 
the relationship between neuroticism and health is more complicated than neuroticism simply 
resulting in worse health or increasing one’s likelihood to partake in risky behaviours that in 
turn results in worse health for everyone or in all situations. Some authors have argued that 
high levels of neuroticism could even have a positive impact on health under certain 
circumstances (e.g., Friedman, 2000; Weston & Jackson, 2015; 2018): either through 
increased vigilance resulting in healthier behaviours in turn, better health or through the 
interaction with other personality traits, conscientiousness in particular.  
Healthy neuroticism has been discussed more in recent literature since Friedman 
(2000) presented the idea that sometimes neuroticism can lead to better health outcomes 
(Friedman, 2019). Friedman (2019) discusses the idea that neuroticism can lead people down 
two paths. The first is a pessimistic and anxious path that causes people to turn to unhealthy 
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or risky behaviours and avoid assistance that could benefit and protect their health. This, in 
turn, creates a negative lifestyle and results in the negative effects of neuroticism. The second 
path is one in which neuroticism results in vigilance and body awareness which in turn results 
in better health and healthy neuroticism. Weston and Jackson (2018) described healthy 
neuroticism as being attentive, noticing changes and being more likely to seek medical 
attention when needed. Another study proposed neuroticism may have positive consequences 
as those who are highly neurotic are more likely to use health services when needed (ten 
Have et al., 2005). Their work examined the use of both primary care and specialised mental 
health care sectors and the use of a mental health contact and the number of mental health 
visits among those high in neuroticism. They found that mental health care users and primary 
care users tended to be higher in neuroticism (ten Have et al., 2005).  
Vigilance. Vigilance has been proposed as one of the key mediating factors in 
forming healthy neuroticism, suggesting that vigilance is often needed to display the 
beneficial effects of neuroticism (Weston & Jackson, 2018). Vigilance refers to body 
awareness and being conscious of one’s symptoms. It is often called body awareness rather 
than vigilance in health research. One study found that a short body awareness program 
found increased quality of life and self-efficacy, emotional improvements, decreased stress 
and an overall positive lifestyle change among its participants (Landsman-Dijkstra, Wijck, 
Groothoff, & Rispens, 2004).  Body awareness has been related to a number of distressing 
bodily symptoms such as somatic complaints and anxiety (Cioffi, 1991). However, a meta-
analysis which looked at body awareness, incorporated studies that examine pain. It was 
noted that mental distractions and attention focused on other mental tasks, were very 
beneficial in limiting pain (Mehling et al., 2009). It is important to note that very few studies 
have looked at vigilance and its relationship with personality. However, body awareness 
research has found that pain and awareness is related to higher neuroticism (Vinck, 1979).  
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Weston and Jackson’s (2018) work examined the relationship between body vigilance 
and neuroticism to see their joint impact on health. The authors note that their study is the 
first to their knowledge that examines the role of vigilance in explaining the relationship 
between neuroticism and health. Their study used 1055 participants from an online 
participant panel assessing self-reported health, Body Mass Index, chronic condition status, a 
composite measure for health behaviours (diet, exercise, alcohol consumption, smoking and 
drug use), and adherence to medication. They hypothesized that neuroticism and body 
vigilance are related and that there is a significant effect of neuroticism on health through 
body vigilance. Weston and Jackson (2018) distinguished between two aspects of body 
vigilance: sensation awareness belief and change awareness belief. Sensation awareness 
belief refers to being aware of sensations and paying attention to sensations in one’s body. 
Change awareness belief refers to being aware of and being able to predict changes in one’s 
body. Neuroticism was significantly related to sensation awareness belief, but unrelated to 
change awareness. The study found partial support for healthy neuroticism via increased 
vigilance: people high in neuroticism scored higher on sensation awareness belief, which in 
turn was related to healthier behaviours. They did however find a negative result in that, 
those higher in neuroticism reported higher sensation awareness belief which in turn related 
to lower self-rated health. 
Conscientiousness. Conscientiousness involves the concepts of following norms and 
rules, being plan and goal oriented, displaying good impulse control and delaying 
gratification (Bogg & Roberts, 2004). Conscientiousness has been found to be an important 
health related trait. On its own, conscientiousness has been found to predict healthy 
behaviours, better physical health and social relationships (Friedman, Kern, Hampson, & 
Duckworth, 2014). Greater conscientiousness has also been associated with lower levels of 
negative affect (Javaras et al., 2012). A meta-analysis has suggested that conscientiousness 
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acts on health outcomes via social environmental factors (e.g. work), health behaviours and 
psychophysiological mechanisms (Bogg & Roberts, 2004). Conscientiousness has been 
related to a large number of traits that are related to positive health outcomes (e.g. hormone 
levels, marital stability, gene expression and socioeconomic status). Conscientiousness was 
found to be negatively associated with all risky health behaviours examined (e.g. tobacco use, 
diet and physical activity patterns, suicide excess alcohol and substance use, violence, risky 
sexual behaviour and dangerous driving) and positively associated with health benefitting 
behaviours (e.g. better diet and exercise habits, less risky sexual behaviour, less alcohol and 
drug use) (Bogg & Roberts, 2004). Conscientiousness has also been proposed as a key factor 
for healthy neuroticism. 
Neuroticism and conscientiousness combined has been examined in the past and 
found to predict lower levels of inflammatory markers (Turiano, Mroczek, Moynihan & 
Chapman, 2013), less smoking and lower alcohol consumption (Turiano, Whiteman, 
Hampson, Roberts & Mroczek, 2012) with high conscientiousness and moderate to high 
neuroticism (Weston & Jackson, 2018).  One study examined the relationship between the 
‘Big Five’ personality traits and interleukin-6 (an inflammatory biomarker). They found 
those who were in the top 10% of the distribution of neuroticism or the bottom 10% of 
conscientiousness had around a 40% greater risk of exceeding relevant levels of interleukin-6 
(Sutin et al., 2010). Interestingly, a follow up study was conducted to examine the possibility 
of ‘healthy’ neuroticism. Their follow up work found that those high in both 
conscientiousness and neuroticism had lower levels of interleukin-6, than people with 
varying levels of conscientiousness and neuroticism. They also found that those high in both 
conscientiousness and neuroticism had lower levels of BMI and chronic disease. They also 
noted that both high and low neuroticism had the same impact on the level of interleukin-6 
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and only the combination of high neuroticism and high conscientiousness resulted in lowered 
levels of interleukin-6 (Turiano et al., 2013).  
Due to the found link between neuroticism and conscientiousness and their joint 
impact on health, more studies have been conducted to examine their effects. One study 
looked at the joint impact of neuroticism and conscientiousness on type 1 diabetes (Brickman 
et al., 1996). The authors state that previous work has found that personality factors such as 
self-esteem, competence, social function and adjustment all influence compliance behaviours 
in relation to type 1 diabetes. It is important to note, that most of these personality factors 
relate to neuroticism or conscientiousness, for example, neuroticism has been related to lower 
self-esteem (Lahey, 2009). 
An earlier study by Weston and Jackson (2015), investigated the effects of 
neuroticism and conscientiousness on health behaviours, namely smoking, after the onset of 
chronic disease. Their study (N = 7015) found that after the onset of major chronic disease, 
high neuroticism coupled with high conscientiousness predicted less smoking. This 
combination (high neuroticism with high conscientiousness) was labelled healthy 
neuroticism. However, healthy neuroticism only influenced smoking after the onset of 
disease and not beforehand. The authors suggest that the relationship between personality and 
one’s response to health problems differs to the relationship between personality and the 
onset of those health problems (Weston & Jackson, 2015).  
One study, which aimed to examine the effects of neuroticism and conscientiousness, 
looked at renal deterioration. Their results found that renal deterioration progressed faster 
among those who were not high in conscientiousness and who were at the extreme low or 
extreme high in neuroticism. Ultimately, they concluded that those who had moderate levels 
of neuroticism and who were high in conscientiousness had renal deterioration times that 
were 12 years longer and therefore, better than average. The authors propose that this positive 
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effect may be due to better self-care, compliance and vigilance due to neuroticism and 
conscientiousness (Brickman et al., 1996).  
Interestingly, both conscientiousness and neuroticism are associated with health-
related social control. It has been suggested that those highly conscientious individuals, have 
their own internalized notions of responsibility and obligation to others rather than others 
trying to influence or improve their health (Tucker, Elliott & Klein, 2006). Also, that their 
‘healthier lifestyles’ are simply qualities such as perseverance, self-discipline, goal-
directedness, and deliberativeness, thus resulting in better health. However, those with higher 
neuroticism experience more attempts from others who are trying to influence or improve 
their health, however they generally display a negative response to this influence. They 
propose that both conscientiousness and neuroticism are related to social control in different 
ways (Tucker et al., 2006). This suggests that those with greater discipline, vigilance and 
conscientiousness results in greater health habits.  
The Present Research  
The present research continued the investigations into the relationship between health 
and neuroticism. It aimed to further examine the relationship between conscientiousness and 
neuroticism.  
Firstly, the present study drew on the vigilance work by Weston and Jackson (2018) 
to examine both change awareness belief and sensation awareness belief and see their effects 
on health outcomes. It also examined the relationship between neuroticism and health to 
further investigate if vigilance is an important mediating factor between neuroticism and 
health. To my knowledge the study by Weston and Jackson (2018) was the first to examine 
the link between neuroticism, vigilance and health outcomes, and whilst some promising 
results were found, replication is needed.  My first hypothesis was that the relationship 
between neuroticism and health outcomes would be mediated by vigilance. 
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Secondly, the present study aimed to look at the relationship between 
conscientiousness and neuroticism, to investigate further if high conscientiousness coupled 
with moderate to high neuroticism results in better health outcomes. I hypothesised that the 
relationship between neuroticism and health outcomes would be moderated by 
conscientiousness. 
Lastly, this study investigated a possible moderated mediation effect of the joint effect 
of vigilance and conscientiousness on the relationship between neuroticism and health 
outcomes. I hypothesised that vigilance would mediate the relationship between neuroticism 
and health outcomes but only for participants high in conscientiousness.   
To examine these hypotheses, two separate samples were recruited. The first study 
reports the findings of a New Zealand sample. The second study reports the findings of a 
United States sample. The aim was to replicate any significant findings from the first study in 
a second, separate, sample in order to show that findings were robust.  
Study 1: New Zealand Sample 
Method 
Participants and Procedure 
Three hundred sixty-nine participants were recruited. The inclusion criteria of this 
study were being an adult (18 years or older) and living in New Zealand. Of the 369 
participants, 31 were removed due to incomplete data and one was removed for being under 
18. This left a final sample of 336 participants: 25.6% (n = 86) were male, 73.8% female (n = 
248), and 0.6% (n = 2) ‘other’. Age varied between 18 and 78 years old, with the mean age 
being 28.10 years (SD = 14.27). Participants were also asked to select what ethnicities they 
identified with (they had the option to select more than one). Of the sample, 85.7% identified 
as New Zealand European (n = 288), 7.4% Māori (n = 25),  6% Asian (n = 20), 2.1% Pacific 
Peoples (n = 7), 0.6% Indian (n = 2), 0.3% Middle Eastern (n = 1), 6.8% European (n = 23) 
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and 5.7% Other (n = 19). Participants were also asked about their highest education, 3.3% did 
not finish high school (n = 11), 61% had finished high school (n = 205), 10.1% had a diploma 
(n =  34), 22% had a Bachelor’s degree (n = 74), 3.3% had a Master’s degree (n = 11) and 
0.3% had a doctorate (n = 1). Participants were recruited either via social media 
advertisement on Facebook (n = 219) and had the option to enter to win one of four $50 gift 
vouchers. The other participants (n = 150) were recruited via the University of Canterbury 
first year Psychology Department participant pool in exchange for course credit (for 
information sheets used, see Appendix A). The study was conducted online via Qualtrics and 
took approximately 20 minutes to complete. This study was reviewed and approved by the 
University of Canterbury Human Ethics Committee (see Appendix B).  
Measures 
Demographics. Demographic measures included questions about participants sex, 
age, ethnicity and highest education. 
Personality. Personality Traits were measured using the Big Five Inventory (BFI) 
(John & Srivastava, 1999).  This is a 44-item inventory that measures the Big Five traits: 
Neuroticism, Conscientiousness, Extraversion, Agreeableness and Openness. Responses are 
measured on a Likert scale from 1 (disagree strongly) to 5 (agree strongly). Many studies 
have found the BFI consistently valid and reliable (Fossati, Borroni, Marchione & Maffei, 
2011; Worrell & Cross, 2004). For example, a study by Alansari (2016) found the BFI to be a 
brief measure of the Big Five but provide consistent reliable and valid results, they found 
neuroticism to have a Cronbach’s alpha of .83 and conscientiousness had a Cronbach’s alpha 
of .90.  Although all 5 personality traits were measured in the survey for the current study, 
only the scales for Neuroticism and Conscientiousness were used. The neuroticism items 
looked at the facets anxiety (tense), angry hostility (irritable), depression (not contented), 
self-consciousness (shy), impulsiveness (moody) and vulnerability (not self-confident). The 
NEUROTICISM AND HEALTH OUTCOMES 14 
eight items asked questions such as “gets nervous easily” and “worries a lot.” The 
conscientiousness items looked at the facets competence (efficient), order (organized), 
dutifulness (not careless), achievement striving (thorough), self-discipline (not lazy) and 
deliberation (not impulsive). The nine items include questions such as “does a thorough job” 
and “perseveres until the job is finished.” Cronbach’s alpha in the current study for 
neuroticism was .84 and .83 for conscientiousness.  
12-Item Short-Form Health Survey. The SF-12 assessed health related quality of 
life in regards to physical and mental health. The physical health aspect looked at limitations 
in moderate and strenuous activities, pain interference and overall health ratings. The mental 
health component looked at energy and calmness levels, emotionality and social time. The 
questions were measured on various scales from not at all to very; and never to all of the 
time.  The questions are all taken from the SF-36 health survey and is a short form of this 
survey as it assess the same 8 domains; physical functioning, role – physical, bodily pain, 
general health perceptions, vitality, social function, role – emotional and mental health 
(Ware, Kosinski and Keller, 1996). There is an algorithm that is used to create the physical 
and mental health component scores to compare to normative data. The mean score is 50, 
with scores over 50 indicating better mental or physical health than the mean and scores 
under 50 indicating worse mental or physical health than the mean (Shirley Ryan Ability Lab, 
2013).  
General Practitioner (GP) Consultations and Care Seeking. Participants were 
asked how often they visit their GP, with answers including less than once a year, once a 
year, twice a year and at least every couple of months. There were also two scenario 
questions i.e.,  “you’ve had a runny nose for two days now, how likely are you to go to the 
doctor?”  and “you’ve had a sharp pain for over a week, how likely are you to go to the 
doctor?” With answers being measured on a 5 point Likert scale from 1 (would definitely go) 
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to 5 (definitely wouldn’t go). The latter two items were combined and then averaged to form a 
scale measuring GP care seeking. The responses were reverse scored so that a higher score 
means higher likelihood of seeking care.   
Body Mass Index (BMI). Participants were asked to report their height (in metres) 
and weight (in kilograms) which was used to calculate their BMI (BMI = kg/m2). A BMI of 
less than 18.5 is underweight, 18.5-24.9 is a normal weight, 25-29.9 is overweight while and 
30+ is obese.     
Health Enhancing and Health Risk Behaviours.  Eating behaviour, physical 
activity, sleep, smoking, alcohol use and drug use were measured.  
Eating Behaviour. Eating behaviour was measured by asking participants on how 
many days in the past two weeks they: ate healthy amounts of food, ate in a balanced way 
with lots of fruits and vegetables, ate junk food (e.g. chocolate and sweets), overate and ate 
fast food (e.g. meat pies and McDonalds) with answers ranging from 1 (every day) to 5 (less 
than once a week). Some of the items were reversed scored so that higher scores refer to 
healthier eating. The 5 items were added to create an eating behaviour measure. Cronbach’s 
alpha for this scale in the current study was .74 (based on Baker, Little & Brownell, 2003; see 
Kuijer & Boyce, 2012; Kuijer Boyce & Marshall, 2015).  
Physical Activity. Physical activity was measured with two questions asking 
participants on how many days in the past 7 days they got 30+ minutes of moderate physical 
activity and on how many days they got 20+ minutes of vigorous physical activity (Ministry 
of Health, 2019). The items were combined and then averaged to form a scale.  
Sleep Quality. Sleep quality was assessed with one item from the Pittsburgh Sleep 
Quality Index (PSQI) asking participants to rate the quality of their sleep in the past month (1 
= worst possible quality, 10 = best possible quality) (Buysse, Reynolds, Monk, Berman & 
Kupfer, 1989).  
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Smoking. Smoking was measured by asking participants if they were smokers, ex-
smokers or never smoked. Ex-smokers and non-smokers were combined into one variable. 
The responses were coded as 1 (smokers) and 2 (non-smokers).   
Alcohol Use. Alcohol use was measured by asking participants how often they drank 
alcohol (never, once a month, up to 4 times a month, 2-3 days a week, 4-5 days a week and 6-
7 days per week). If they did drink alcohol, they were also asked how many standard drinks 
containing alcohol they had on a typical day when drinking. The items were multiplied (days 
and amount) to create a measure of alcohol use.  
Drug Use.  Drug use was measured by asking “During the past month, how many 
times did you use illicit drugs?” (haven’t used, once, 2-3 times, several times)  Less than 20% 
of the sample reported having used any drugs (9.8% once, 6.0% 2-3 times, 3.6% several 
times), hence it was decided to dichotomize the item and code responses as 1 (not used in the 
past month) and 2 (used in past month).    
Outcomes measures for both studies are included in Appendix C, except for the BFI, 
SF-12 and sleep questionnaires due to copyright.  
Vigilance. Body vigilance was measured using the questionnaire compiled by Weston 
and Jackson (2018). They complied the scale using five existing vigilance scales; the Body 
Awareness Questionnaire (BAQ) (Shields, Mallory, & Simon, 1989), the Private Body 
Consciousness sub- scale of the Body Consciousness Questionnaire (PBCS) (Miller, Murphy, 
& Buss, 1981), the Scale of Body Awareness (SBA) (Hansell & Sherman, 1991), the Body 
Responsiveness Questionnaire (BRQ) (Daubenmier, 2005), and the Body Vigilance Scale 
(BVS) (Schmidt & Lerew, 1997).  A factor analysis was conducted of the 38 items from the 5 
scales, they extracted two factors with 35 items. The two factors were labelled Change 
Awareness Belief (18 items) and Sensation Awareness Belief (17 items). The change 
awareness factor was identified as the items reflected the idea that one could predict changes 
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in their body and included items such as “I know in advance when I’m getting the flu” and “I 
am very aware of changes in my body temperature.” The sensation awareness belief factor 
was identified as the items seemed to reflect that one thinks about the changes and feeling in 
their body and included items such as “I am sensitive to internal bodily tensions” and “I can 
often feel my heart beating” (see Appendix D for full scale). In the 35-item scale, most items 
are rated a scale from 1 (strongly disagree) to 5 (strongly agree), while some are rated from 1 
(Never) to 5 (Always). The Cronbach’s alphas in the present study were α = .81 for change 
awareness belief and α = .87 for sensation awareness belief.   
Analyses  
Analysis consisted of mediation, moderation and moderated mediation analysis. All 
analyses were conducted using the PROCESS Macro for SPSS (Hayes, 2013).  Age and sex 
were entered as covariates for all analyses. For the mediation analysis, unstandardized 
indirect effects were calculated for each of 10,000 bootstrapped samples. A 95% confidence 
interval was used by calculating the indirect effects at the 2.5th and 97.5th percentiles. To have 
obtained a significant result, the confidence intervals must not include zero.  
A moderation variable affects the direction or strength between two variables. For the 
moderator analyses, the predictor variable (neuroticism), the moderator variable 
(conscientiousness) and the interaction term (neuroticism X conscientiousness) were entered 
in the model. Significant moderation effects were followed up with simple slope analyses at 
one standard deviation above the mean of the moderator, at the mean and at one standard 
deviation below the mean of the moderator.   
The moderated mediation analysis (using model 8 from the PROCESS Macro) 
examined the effect of an independent variable on an outcome variable via a mediator 
variable depending on a moderator variable. A 95% percentile bootstrap confidence interval 
is created using 5000 bootstrap samples for the conditional indirect effect at -1 standard 
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deviation, 0 standard deviation and +1 standard deviation of the moderator. To have obtained 
a significant result the confidence intervals must not include zero (Hayes, 2013).   
Results 
Descriptive Analyses 
Table 1 displays the means and standard deviations for the key variables in the study. 
Compared to normative data for the SF-12, the sample scored below average on mental 
health (i.e., below 50) and above average (i.e., above 50) on physical health. The average 
participant visited their GP between one and two times per year and would probably not seek 
care for a runny nose or sharp pain (the two hypothetical scenarios). The average BMI sat just 
inside the overweight range. Participants reported fairly healthy eating behaviours, moderate 
physical activity and above average sleep quality. While only 5.1% of participants were 




Descriptive Results for Key Variables 
 M (or N) SD (or %) Possible range 
Mental Health Component (SF-12) 43.57 11.62 0-100 
Physical Health Component (SF-12) 53.13 8.17 0-100 
GP Consultations 2.66 1.09 0-4 
GP Care Seeking 2.07 0.50 0-4 
BMI 25.30 5.13  
Eating Behaviour 4.20 1.45 1-5 
Physical Activity 4.27 1.90 1-8 
Alcohol Use 7.18 5.20 1-36 
Drug Use (in past month) 65 19.3%  
Sleep 6.30 1.80 1-10 
Smoking (current) 17 5.1%  
Sensation Awareness Belief  2.96 0.65 1-5 
Change Awareness Belief 3.35 0.55 1-5 
Conscientiousness 3.57 0.67 1-5 
Neuroticism 3.08 0.80 1-5 
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Table 2 presents the correlations between neuroticism, conscientiousness, and the two 
vigilance measures with age, sex and the health variables (correlations between the whole set 
of variables are displayed in Appendix E). Neuroticism was significantly negatively 
associated with age, the mental health component, physical activity, eating behavior, sleep, 
smoking, change awareness and positively associated with GP consultations, drug use and 
sensation awareness. Conscientiousness was significantly negatively associated with alcohol 
use and drug use but positively associated with sex, age, mental health component, eating 
behavior, physical activity, smoking and change awareness belief. Neuroticism and 




Correlations between Personality, Vigilance, Demographics and Health Variables 




Sex 0.08                 0.23**                    0.13*                   0.09 
Age -0.34**              0.43**                     0.06                   -0.04 
Mental Health Comp.  -0.67**            0.28*                      0.11*                -0.10 
Physical Health Comp. 0.00               0.07                        0.03                  -0.14* 
GP Consultations  0.19** 0.02 0.05 0.14** 
GP Care Seeking 0.01 0.03 -0.04 0.98 
BMI 0.05 -0.02 0.04 0.08 
Eating Behaviour -0.37** 0.45** 0.14** 0.01 
Physical Activity -0.21** 0.17** 0.07 0.14* 
Alcohol Use 0.01 -0.25** -0.05 -0.02 
Drug Use 0.19** -0.25** -0.02 0.09 
Sleep -0.23** 0.06 0.09 -0.07 
Smoking (current) -0.02               0.11*                        0.01                  -0.00 
Sensation Awareness B. 0.16* 0.02 0.43**  
Change Awareness B. -0.06                    0.20**                     
Conscientiousness -0.30**                        
Neuroticism     
Note: ** Correlation is significant at the 0.01 level (2-tailed), * Correlation is significant at 
the 0.05 level (2-tailed).  Sex: 1 = male, 2 = female; Drug use: 1 = user, 2 = non-user; 
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Mediation  
A series of mediation models were run to test the hypothesis that vigilance mediates 
the relationship between neuroticism and health related outcomes. In these analyses the two 
measures of body vigilance (sensation awareness belief and change awareness belief) were 
included as mediators. Separate analyses were run for each dependent variable. Because age 
and sex were related to some of the health variables (see Appendix E) and/or to the predictor 
or mediator variables (see Table 2) they were included as covariates in all analyses. The 
results are presented in Table 3.   
Neuroticism was found to be a significant predictor of sensation awareness belief (b = 
0.13, t = 2.89, p = .00) but not a significant predictor of change awareness belief (b = −0.04, t 
= −1.14, p = 0.26) (the ‘a’ paths in Table 3). No indirect effects of neuroticism through 
change awareness belief were found (i.e., all the confidence intervals for the indirect effect of 
change awareness included 0, see Table 3). As shown in Table 3, there was only one 
significant mediation effect through sensation awareness belief for the physical health 
component (indirect effect = -0.30, [-0.61, -0.05]). This indirect effect suggests that higher 
neuroticism is related to higher sensation awareness belief, which in turn is related to, poorer 
physical health. Neuroticism was significantly related to many of the outcome variables (seen 
in the significant direct effects in Table 3) however, vigilance did not mediate the effect 
between them.  
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Table 3 
 
Mediation Effects between Neuroticism and Health Outcomes for the New Zealand Sample 
 
 Total Effect Direct Effect  Indirect Effect   
        b        95%CI        b        95%CI         b        95%CI       a path    b path 
          
MHC -9.23*** [-10.48, -7.98] -9.09*** [-10.36, -7.81] Total -0.15 [-0.50, 0.15]   
     Sense -0.08 [-0.35, 0.15]      0.13**      -0.61 
     Change -0.07 [-0.33, 0.08] -0.04 1.68 
          
PMC -0.29 [-1.48, 0.90]       0.09  [ -1.10, 1.29]               Total -0.38 [-0.75, -0.09]   
     Sense -0.30 [-0.61, -0.05] 0.13**    -2.39** 
     Change -0.08 [-0.36, 0.09]  -0.04 1.99 
          
GP Consult 0.27***       [0.12, 0.42]  0.24*** [0.08, 0.39]  Total 0.03 [-0.01, 0.75]   
     Sense 0.02 [-0.00, 0.07]  0.13** 0.20* 
     Change 0.00 [-0.01, 0.02]  -0.04 0.66 
          
GP Care  0.01 [-0.07, 0.08]  0.00 [-0.07, 0.07] Total 0.00 [-0.01, 0.03]   
     Sense 0.00 [-0.01, 0.02] 0.13** 0.01 
     Change 0.00 [-0.01, 0.01] -0.04 -0.06 
          
BMI 0.89* [0.18, 1.60] 0.82* [0.09, 1.54] Total 0.07 [-0.09, 0.22]   
     Sense 0.08 [-0.03, 0.20] 0.13** 0.61 
     Change -0.01 [-0.09, 0.06] -0.04 0.12 
          
Eating  -0.26*** [-0.35, -0.16] -0.25*** [-0.35, -0.16] Total -0.00 [-0.03, 0.02]   
     Sense 0.00 [-0.01, 0.02] 0.13** 0.01 
     Change -0.01 [-0.25, 0.01] -0.04 0.14 
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Table 3 (continued) 
 
Mediation Effects between Neuroticism and Health Outcomes for the New Zealand Sample 
 
 Total Effect Direct Effect  Indirect Effect   



















     Sense 0.01 [-0.04, 0.07] 0.13** 0.09 
     Change -0.02 [-0.08, 0.02] -0.04 0.49* 
          
          
Alcohol -0.45 [-1.16, 0.26] -0.45 [-1.20, 0.27] Total -0.00 [-0.17, 0.16]   
     Sense -0.00 [-0.15, 0.14] 0.13** -0.02 
     Change 0.00 [-0.07, 0.07] -0.04 -0.06 
          
Drug1   0.45* [0.05, 0.86] Total 0.05 [-0.04, 0.15]   
     Sense 0.04 [-0.02, 0.13] 0.13** 0.34 
     Change 0.00 [-0.04, 0.05] -0.04 -0.08 
          
Sleep -0.57*** [-0.83, -0.03] -0.52*** [-0.79, -0.26] Total -0.05 [-0.13, 0.01]   
     Sense -0.03 [-0.06, 0.01] 0.13** -0.25 
     Change -0.02 [-0.04, 0.01] -0.04 0.43* 
          
Smoking1   0.02 [-0.66, 0.70] Total -0.10 [-0.29, 0.07]   
     Sense -0.07 [-0.22, 0.07] 0.13** -0.56 
     Change -0.03 [-0.17, 0.05] -0.04 0.77 
     
1 Total effects cannot be computed for dichotomous variables.  
* p < 0.05, ** p <0.01, *** p <0.00 
All analyses controlled for age and sex. 
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Moderation 
Next, moderation analyses were conducted to examine if conscientiousness moderated 
the relationship between neuroticism and health outcomes. Separate analyses were again run 
for each dependent variable and sex and age were entered as covariates. The results for this 
analysis are presented in Table 4. Table 4 shows that there was a significant interaction effect 
for the mental health component. The interaction effect is displayed in Figure 1. Figure 1 
shows that neuroticism was related to worse mental health for all participants, but that this 
relationship was strongest for those with low levels (1 SD below the mean) of 
conscientiousness (b = -10.54, SE = .88, t = -11.94, p < .001), less strong for participants with 
average levels of conscientiousness (b = -.9.18, SE = .65, t = -14.25, p < .001) and weakest 
for those with high levels (1 SD above the mean) of conscientiousness (b = -7.81, SE = .81, t 
= -9.66, p < .001). No other moderation effects were found.  
Table 4 shows that low neuroticism and high conscientiousness were both 
independently related to healthier eating behaviours and greater physical activity.  
Figure 1  
Moderation Effect of Conscientiousness on Neuroticism and Mental Health Component 
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Moderation Effects of  Conscientiousness between Neuroticism and Health Outcomes for the New Zealand Sample.  
  
 
  Neuroticism  Conscientiousness  Interaction   
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BMI 0.86 0.37 2.31 -0.63 0.47 -1.34 -0.57 0.47 -1.21 0.08*** 0.00 
            
Eating -0.20 0.05 -4.41*** -0.31 0.06 5.39*** 0.11 0.06 1.95 0.30*** 0.01 
            
Phys Act -0.46 0.14 -3.36*** 0.62 0.17 3.62*** -0.08 0.17 -0.46 0.10*** 0.00 
            
Alcohol -0.62 0.36 -1.69 -0.10 0.46 -2.16* -0.43 0.46 -0.93 0.15*** 0.00 
            
Drug1 0.34 0.21 1.622 -0.49 0.26 -1.882 -0.42 0.28 -1.492   
            
Sleep -0.57 0.13 -4.25*** 0.06 0.17 0.37 0.32 0.17 1.89 0.07*** 0.01 
            
Smoking1 0.33 0.40 0.822 1.13 0.48 2.34*2 0.62 0.40 1.552   
1 R2 cannot be computed for dichotomous variables 
2  Z values are presented for dichotomous variables 
* p < 0.05, ** p <0.01, *** p <0.00 




Moderation Effects of Conscientiousness between Neuroticism and Health Outcomes for the New Zealand Sample 
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Moderated Mediation 
Finally, moderated mediation analyses were conducted to examine if vigilance 
mediated the relationship between neuroticism and health outcomes but only for those high in 
conscientiousness. The analysis displays an index for moderated mediation. If the 95% 
confidence interval of the effect does not include zero, there is evidence for moderated 
mediation. Separate analyses were again run for each of the dependent variables. None of the 
analyses found significant moderated mediation results.  
Summary of Study 1 Findings 
For the New Zealand sample, few significant mediation or moderation results were 
found. One significant mediation effect through sensation awareness belief was found for the 
physical health component. This effect suggested that higher neuroticism is related to higher 
sensation awareness belief, which in turn is related to poorer physical health. One significant 
moderation effect was also found for the mental health component. Those high in neuroticism 
tended to have the lower mental health scores. Those high in neuroticism and low 
conscientiousness seemed to have the lowest mental health scores. This interaction displayed 
that neuroticism is related to mental health and the relationship is slightly attenuated by high 
conscientiousness.  No significant moderated mediation results were found.  
 
Study 1: United States Sample 
Method 
Participants and Procedure 
Two hundred and eighteen participants were recruited via Mechanical Turk. 
Participants had to be over 18 years old, English Speaking and in North America.  Of these, 
13 were removed for not finishing the study, 2 data sets were removed due to someone 
answering twice with different answers (this was spotted via their Mechanical Turk worker 
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ID), 4 were removed due to failing the attention checks. This left a final sample of 199 
participants, 53.2% (n = 106) were male, 45.7% (n = 91) females and 1.1% (n = 2) other. Age 
varied between 18 and 72 years old (M = 38.2, SD = 11.28). The ethnic composition of 
participants was 76.3% White or Caucasian European (non-Hispanic) (n = 151), 5.1% 
Black/African American (n = 10), 6.6% Hispanic or Latino American (n = 13), 8.6% Asian 
American (n = 17), 1.5% Native or Indigenous American (n = 3) and 2% Other (n = 4). 
Participants were also asked their highest education, 0.5% had not finished high school (n = 
1), 29.6% had a high school qualification (n = 59), 24.1% had an Associate’s degree (n = 48), 
36.7% had a Bachelor’s degree (n = 73), 7.5 had a Master’s degree (n = 15) and 1.5% had a 
Doctorate (n = 3). Participants were recruited via Amazon Mechanical Turk (for information 
sheets used, see Appendix A). They were each paid USD$2 for their time. The study was 
conducted online via Qualtrics and took approximately 20 minutes to complete. This study 
was reviewed and approved by the University of Canterbury Human Ethics Committee (see 
Appendix B). 
Measures 
Demographics. Demographic measures included questions about participants sex, 
age, ethnicity and highest education.  
Personality. Neuroticism and Conscientiousness were assessed with the same 
questions as in Study 1 (John & Srivastava, 1999). Cronbach’s alpha for Neuroticism was .92 
in the current study, and .91 for Conscientiousness. 
12-Item Short-Form Health Survey. The SF-12 was again used to assess health 
related quality of life in regards to physical and mental health components. 
Family Physician Consultations. Participants were asked how often they visited 
their family physician with answers ranging from less than once a year to at least every 
couple of months. They were also asked the same two scenario questions as used in Study 1, 
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i.e., . “you’ve had a runny nose for two days now, how likely are you to go to the family 
physician?”  and “you’ve had a sharp pain for over a week, how likely are you to go to the 
family physician?” 1 (would definitely go) to  5 (definitely wouldn’t go). 
Body Mass Index. Participants were asked to report their height (in inches) and 
weight (in pounds).  
Health Risk Behaviours.  Smoking, diet, alcohol, drug use and physical activity 
were all measured with the same questions as in Study 1.  
Eating Behaviour.  For the eating behaviour measure,  the consumption of fast food  
(e.g. meat pies, McDonalds) was reworded to suit American fast food items more (e.g. pizza, 
KFC and McDonalds). Cronbach’s alpha for the eating behaviour item scale was .71 in the 
current study  (based on Baker et al., 2003; see Kuijer & Boyce, 2012; Kuijer et al., 2015).  
Physical Activity. Physical activity was again measured using three questions. The 
first two components were combined to create a measure of physical activity using days per 
week (Ministry of Health, 2019). 
Smoking.  Smoking was measured by asking if participants if they are smokers, ex-
smokers or never smoked. Ex-smokers and non-smokers were again combined into one 
variable.  
Alcohol Use. Alcohol use was measured by asking participants how often they drank 
alcohol and they were also asked how many standard drinks containing alcohol they had on a 
typical day when drinking The items were multiplied (days and amount) to create a measure 
of alcohol use.  
Drug Use. Drug use was measured by asking during the past month, how many times 
they have used illicit drugs (haven’t used, once, 2-3 times, several times). Less than 8% of 
the sample reported having used any drugs, hence it was decided to dichotomize the item and 
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code responses as 1 (not used in the past month) and 2 (used in past month).    
Sleep. Sleep was assessed with one item from the Pittsburgh Sleep Quality Index 
(PSQI) (Buysse et al., 1989).  
Vigilance. Body vigilance was measured using the questionnaire developed by 
Weston and Jackson (2018). This measure saw the items being split into two factors; change 
awareness belief (α = .85) and sensation awareness belief (α = .89). 
Analyses. Analysis consisted of mediation, moderation and moderated mediation 
analyses and were conducted the same as the New Zealand sample.  
Results 
Descriptive Analyses 
Table 5 displays all the descriptive analysis for the key variables in the study. Similar 
to the New Zealand sample, the sample scored below average on mental health (i.e., below 
50) and above average (i.e., above 50) on physical health. Also, the same as the New Zealand 
sample, the average participant visited their family physician between one and two times per 
year and would probably not seek care for a runny nose or sharp pain. The average BMI was 
just inside the overweight range. Participants reported less healthy eating and physical 
activity than the New Zealand sample however, reported better sleep quality. Unlike the New 
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Table 5 
 
Descriptive Results for Key Variables 
 M (or N) SD (or %) Possible range 
Mental Health Component (SF-12) 44.01 13.43 0-100 
Physical Health Component (SF-12) 52.60 8.04 0-100 
GP Consultations 2.01 1.02 0-4 
GP Care Seeking 2.01 0.60 0-4 
BMI 26.47 6.30  
Eating Behaviour 3.76 0.71 1-5 
Physical Activity 3.62 1.88 1-8 
Alcohol Use 4.06 4.83 1-36 
Drug Use (in past month) 15 7.5%  
Sleep 6.57 1.84 1-10 
Smoking (current) 33 16.6%  
Sensation Awareness Belief  2.91 0.71 1-5 
Change Awareness Belief 3.38 0.65 1-5 
Conscientiousness 3.96 0.82 1-5 
Neuroticism 2.61 1.06 1-5 
 
Table 6 presents the correlations between neuroticism, conscientiousness and the two 
vigilance measures with age, sex and the health variables (correlations between the whole set 
of variables are displayed in Appendix F). Similar to the New Zealand sample, neuroticism 
was negatively correlated with age, the mental health component and sleep. It was also 
positively correlated with drug use and sensation awareness. Conscientiousness was 
negatively correlated with drug use and positively associated with age, the mental health 
component, eating behaviour, physical activity and change awareness belief. Unlike the New 
Zealand sample, conscientiousness was positively associated with sleep.  Neuroticism and 
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Table 6 
 
Correlations between Personality, Vigilance, Demographics and Health Variables 




Sex 0.20**                -0.03                    -0.05                   0.08 
Age -0.19**              0.30**                     -0.01                   -0.10 
Mental Health Comp.  -0.72**            0.55**                      0.05                -0.29** 
Physical Health Comp. 0.12              0.07                        0.08                  -0.03 
GP Consultations  -0.08 0.08 0.04 0.08 
GP Care Seeking -0.06 0.10 0.09 0.10 
BMI -0.07 -0.03 -0.11 -0.09 
Eating Behaviour -0.12 0.29** 0.15* 0.00 
Physical Activity -0.14 0.18* 0.27** 0.08 
Alcohol Use 0.07 -0.11 0.03 0.97 
Drug Use 0.19** -0.25** -0.02 0.09 
Sleep -0.36** 0.20** 0.02 -0.28** 
Smoking (current) 0.12              -0.02                        0.03                  -0.02 
Sensation Awareness B. 0.27** -0.05 0.55**  
Change Awareness B. -0.05                   0.27**                     
Conscientiousness -0.54**                        
Neuroticism     
Note: ** Correlation is significant at the 0.01 level (2-tailed), * Correlation is significant at 
the 0.05 level (2-tailed).  Sex: 1 = male, 2 = female; Drug use: 1 = user, 2 = non-user; 
Smoking: 1 = smoker, 2 = non-smoker 
Mediation  
Another series of mediation analysis were conducted, the same as the New Zealand 
sample. Age and sex were again entered as covariates. The results are presented in Table 7. 
Similar to the New Zealand sample, neuroticism was found to be a significant predictor of 
sensation awareness belief (b = 0.17, t = 3.55, p = .001) but not a significant predictor of 
change awareness belief (b = −0.03, t = −0.61, p = 0.55) (the ‘a’ paths in Table 7). Matching 
the New Zealand study, no indirect effects of neuroticism through change awareness belief 
were found. However, unlike the New Zealand sample, very few direct effects were found 
meaning neuroticism was not related to many of the outcome variables.  This sample 
obtained two significant mediation effects through sensation awareness belief for the mental 
health component (indirect effect = -0.63 [-1.35, -0.16]) and sleep (indirect effect = -0.15 [-
0.27, -0.04]).  This indirect effect suggests that higher neuroticism is related to higher 
sensation awareness belief, which in turn is related to, poorer mental health and poorer sleep. 
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Table 7 
 
Mediation Effects between Neuroticism and Health Outcomes in the United States Sample 
 
 Total Effect Direct Effect  Indirect Effect   
        b        95%CI        b        95%CI         b        95%CI         a path       b path 
          
MHC -9.09*** [-10.35, -7.82] -8.38*** [-9.70, -7.07] Total -0.71 [-1.36, -0.22]   
     Sense -0.63 [-1.35, -0.16]      0.17***      -3.67*** 
     Change -0.08 [-0.41, 0.21] -0.03     2.85** 
          
PMC 0.66 [-0.44, 1.77]       1.05 [ -0.11, 2.21]               Total -0.38 [-0.89, -0.00]   
     Sense -0.31 [-0.85, 0.02]      0.17*** -1.90 
     Change -0.06 [-0.32, 0.16]  -0.03 2.10 
          
GP Consult -0.09       [-0.23, 0.05]  -0.12 [-0.27, 0.03]  Total 0.03 [-0.02, 0.10]   
     Sense 0.03 [-0.02, 0.09]       0.17*** 0.17 
     Change 0.00 [-0.02, 0.02]  -0.03 -0.03 
          
GP Care  -0.03 [-0.12, 0.05]  -0.05 [-0.14, 0.04] Total 0.01 [-0.02, 0.06]   
     Sense 0.02 [-0.01, 0.06]      0.17*** 0.09 
     Change -0.00 [-0.01, 0.01] -0.03 0.02 
          
BMI -0.26 [-1.14, 0.62] -0.28 [-1.21, 0.65] Total 0.02 [-0.28, 0.31]   
     Sense -0.01 [-0.28, 0.24]      0.17*** -0.06 
     Change 0.03 [-0.09, 0.20] -0.03 -1.10 
          
Eating  -0.09 [-0.19, 0.01] -0.07 [-0.17, 0.03] Total -0.02 [-0.06, 0.02]   
     Sense -0.01 [-0.05, 0.02]      0.17*** -0.07 
     Change -0.01 [-0.03, 0.01] -0.03 0.21* 
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Table 7 (continued) 
 
Mediation Effects between Neuroticism and Health Outcomes in the United States Sample  
 
 Total Effect Direct Effect  Indirect Effect   



















     Sense 0.02 [-0.12, 0.07]      0.17*** -0.10 
     Change -0.02 [-0.11, 0.06] -0.03 0.78*** 
          
          
Alcohol -0.62 [-0.04, 1.28] -0.46 [-0.24, 1.16] Total 0.16 [-0.06, 0.48]   
     Sense 0.15 [-0.04, 0.46]      0.178** 0.90 
     Change 0.01 [-0.06, 0.09] -0.03 -0.36 
          
Drug1   -0.11 [-0.68, 0.46] Total 0.01 [-0.24, 0.26]   
     Sense -0.00 [-0.23, 0.23]      0.17*** -0.01 
     Change 0.01 [-0.06, 0.11] -0.03 -0.51 
          
Sleep -0.68** [-0.92, -0.44] -0.52*** [-0.76, -0.27] Total -0.16 [-0.28, -0.06]   
     Sense -0.15 [-0.27, -0.04]      0.17*** -0.86*** 
     Change -0.16 [-0.09, 0.04] -0.03 0.56* 
          
Smoking1   0.37 [-0.06, 0.79] Total -0.07 [-0.25, 0.09]   
     Sense -0.06 [-0.23, 0.08]      0.17*** -0.33 
     Change -0.01 [-0.09, 0.04] -0.03 0.34 
1 Total effects cannot be computed for dichotomous variables.  
* p < 0.05, ** p <0.01, *** p <0.00 
All analyses controlled for age and sex. 
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Moderation 
Moderation analyses were conducted to examine if conscientiousness moderated the 
relationship between neuroticism and health outcomes. Sex and age were again entered as 
covariates. The results for this analysis are presented in Table 8. Table 8 shows that there was 
a significant interaction effect for the physical health component. Figure 2 shows the 
interaction effect. This shows that neuroticism is related to better physical health only for 
those with low (b = 2.82, SE = .82, t = 3.43, p < .001) or average (b = 1.77, SE = .65, t = 2.82, 
p < .05) conscientiousness. Participants with high conscientiousness (b = 0.72, SE = .80, t = 
0.90, p = 3.66) had better physical health regardless of their levels of neuroticism. This 
suggests that low or average levels of conscientiousness can be compensated for by higher 
levels of neuroticism. No other moderation effects were found.  
 
Figure 2 
Moderation Effect of Conscientiousness on Neuroticism and Physical Health Component 
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Table 8 
 
Moderation Effects of  Conscientiousness between Neuroticism and Health Outcomes for the United States Sample 
 
  Neuroticism  Conscientiousness  Interaction   
     b   S.E        t         b S.E        t b        S.E        t     R2 R2  Change 
            









   















            
 GP Consult -0.76     0.08 -0.90 0.02 0.11 0.14 0.09 0.08 1.12 0.03 0.01 
 























            
BMI -0.59 0.52 -1.15 -0.85 0.71 -1.21 -0.04 0.52 -0.09 0.02 0.00 
            
Eating  0.03 0.06 0.54 0.33 0.07 4.36*** -0.09 0.06 -1.57 0.12*** 0.01 
            
Phys Act -0.11 0.15 -0.79 0.52 0.20 2.54* -0.06 0.15 -0.37 0.08* 0.00 
            
Alcohol 0.41 0.39 1.05 -0.53 0.53 -1.00 0.00 0.39 0.01 0.06* 0.00 
            
Drug1 -0.56 0.37 -1.502 -0.73 0.41 -1.802 -0.32 0.27 -1.202   
            
Sleep -0.62 0.14 -4.38*** 0.15 0.19 0.80 0.01 0.14 0.04 0.15*** 0.00 
            
Smoking1 0.36 0.24 1.502 0.15 0.30 0.512 -0.13 0.25 -0.532   
 
1 R2 cannot be computed for dichotomous variables 
2  Z values are presented for dichotomous variables 
* p < 0.05, ** p <0.01, *** p <0.00 
All analyses controlled for age and sex. 
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Moderated Mediation 
Finally, moderated mediation analyses were conducted to examine if vigilance 
mediated the relationship between neuroticism and health outcomes but only for those high in 
conscientiousness. Separate analyses were again run for each of the dependent variables. 
Comparable to the New Zealand sample, none of the analyses found significant moderated 
mediation results.  
Summary of Study 1 Findings 
 
For the United States sample, similar to the New Zealand sample, very few significant 
mediation and moderation results were found. Two significant mediation effects through 
sensation awareness belief were found for the mental health component and sleep rating. This 
effect suggests that higher neuroticism is related to higher sensation awareness belief, which 
in turn is related to, poorer mental health and poorer sleep. One significant moderation effect 
was also found for the physical health component indicating that those low in neuroticism 
and low in conscientiousness had the lower physical health scores. Those high in 
conscientiousness had overall better physical health. No significant moderated mediation 
results were found.  
Discussion 
 
The present research aimed to explore three key hypotheses that related health 
outcomes to neuroticism. The first being that vigilance mediated the relationship between 
neuroticism and health outcomes. The second being that conscientiousness moderated the 
relationship between neuroticism and health outcomes. The third and final hypothesis was 
vigilance coupled with conscientiousness would have a mediator-moderator effect on health 
outcomes. Overall, the present research found very little support for the hypotheses.  
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Vigilance 
The first hypothesis was that vigilance would mediate the relationship between 
neuroticism and health outcomes. In the current research, little support was found for 
mediation in either sample. In line with Weston and Jackson (2018), neuroticism was found 
to be significantly related to sensation awareness belief, but not to change awareness belief. 
This was true in both the New Zealand and the United States sample. This ruled out change 
awareness as a mediator. Weston and Jackson’s (2018) finding of a relationship between 
sensation awareness belief and neuroticism was replicated in the present research. However, 
the present research indicated neuroticism is related to higher sensation awareness belief, 
which in turn, resulted in poorer health outcomes. Whereas Weston and Jackson (2018) found 
neuroticism was related to better health behaviours through sensation awareness belief. They 
determined this finding to be evidence towards the theory that neuroticism and vigilance are 
related.  
The present research examined eleven dependent variables. Only one significant 
mediation result was found with sensation awareness in Study 1, and two in Study 2. 
Moreover, the findings were not replicated across the two studies. While the present research 
did not examine the exact same variables as Weston and Jackson (2018) who examined self-
rated health and healthy behaviour, self-reported health was measured in the SF-12 and used 
for the physical and mental health scores. However, while some findings in this research 
were similar to Weston and Jackson (2018), the findings were not replicated across the New 
Zealand and United States samples.   The New Zealand sample found one significant result 
for sensation awareness belief mediating the relationship between neuroticism and physical 
health which suggested that higher neuroticism is related to higher sensation awareness 
belief, which in turn is related to, poorer physical health. This is in line with Weston and 
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Jackson (2018) who found that those higher in neuroticism reported higher sensation 
awareness belief which in turn related to lower self-rated health.  
While the United States sample found two significant findings for sensation 
awareness belief mediating the relationship between neuroticism and mental health and sleep. 
This again suggests that higher neuroticism is related to higher sensation awareness belief, 
which in turn is related to, poorer mental health and poorer sleep. It is possible that sensation 
awareness belief may result in poorer mental and physical health and poorer sleep habits due 
to making those individuals more aware of their body and feelings. Similar to the findings in 
Study 1, those higher in neuroticism reported higher sensation awareness belief which in turn, 
related to poorer mental health. This is in line with Weston and Jackson’s (2018) finding of 
sensation awareness belief being related to lower self-rated health. However, Weston and 
Jackson did not examine sleep in their study.  
Weston and Jackson (2018) found sensation awareness belief to be a significant 
mediator between BMI and neuroticism, something that was not replicated in the present 
research. They also found sensation awareness belief to be a significant mediator between 
chronic condition status and neuroticism which was not examined in the present research. 
Perhaps, it is most important to note that Weston and Jackson (2018) found support for 
healthy neuroticism. Sensation awareness belief was a significant mediator between healthy 
behaviour (a factor which included drug use, alcohol use, smoking, eating behaviour and 
physical activity) and neuroticism, which indicated that the indirect effect of neuroticism was 
positive. This suggested, that when a person’s neuroticism leads to vigilance, that person acts 
in healthier ways. No significant mediation results were found for any of these variables in 
the present research.   
Body awareness has been related to a number of distressing bodily symptoms such as 
somatic complaints and anxiety (Cioffi, 1991). It is possible that those who are more aware of 
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their bodily sensations, are more aware of the negative feelings in their body and in turn, 
report lower mental and physical health. Increased vigilance and attention towards the body 
may be why those who are more neurotic report more somatic complaints (Weston & 
Jackson, 2018).  
Conscientiousness 
The second hypothesis was that conscientiousness would moderate the relationship 
between neuroticism and health outcomes. Conscientiousness has been found in the past to be 
negatively associated with risky behaviours such as drug use and alcohol use and positively 
associated with health benefitting behaviours (Bogg & Roberts, 2004).  This was supported in 
the present research, as conscientiousness was negatively correlated with these risk factors 
and positively correlated to eating and physical activity in both studies.   
Both samples only found one significant moderation effect, for the New Zealand 
sample this was with mental health component as the dependent variable. High neuroticism 
was found to be related to poorer mental health. Neuroticism alone has been linked to many 
mental illnesses, such as anxiety and depression (Liu & Lin, 2019) therefore it is unsurprising 
that those high in neuroticism reported the lowest mental health scores. This relationship was 
strongest for participants with low levels of conscientiousness and weakest (but still highly 
significant) for participants with high levels of conscientiousness. These findings suggest that 
high levels of conscientiousness can attenuate the negative effect of neuroticism slightly. No 
support for healthy neuroticism was found as those who were high in both conscientiousness 
and neuroticism are not reporting the highest mental health scores. However, those high in 
both conscientiousness and neuroticism were slightly better off than those who were high in 
neuroticism and low in conscientiousness. High conscientiousness and moderate levels of 
neuroticism have been found to have a positive effect on health in past research (Brickman et 
al., 1996; Weston & Jackson, 2018).  Conscientiousness is generally associated with healthier 
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behaviours and high conscientiousness has been associated with less negative affect (Javaras 
et al., 2012; Friedman et al., 2014). 
In the United States sample, the one moderation effect was found with the physical 
health component. Conscientiousness on its own has been related to better physical health 
(Friedman et al., 2014) therefore it is to be expected that those high in conscientiousness had 
the greatest physical health scores. The moderation effect shows neuroticism is positively 
related to greater physical health but only for those with low or average levels of 
conscientiousness. Those with high levels of conscientiousness have the greatest physical 
health scores, regardless of their level of neuroticism. This suggests that low or average 
levels of conscientiousness can be compensated for by higher levels of neuroticism. This 
indicates support for the theory that high neuroticism and high conscientiousness interact in a 
positive and protective manner and supports the idea of healthy neuroticism. High 
neuroticism and high conscientiousness have been found to have positive effects on physical 
health in past research. For example, lower levels on an inflammatory biomarker (Sutin et al., 
2010).  
Moderated Mediation 
The third and final hypothesis was vigilance coupled with conscientiousness would 
have a mediator-moderator effect on health outcomes. No evidence was found for moderated 
mediation in either sample. Given the very few mediation and moderation effects that were 
found in the separate mediation and moderation analyses, this is not surprising.  The aim of 
this analysis was to explore the idea that vigilance would mediate the relationship between 
neuroticism and health outcomes but only for participants high in conscientiousness. While 
the present research did not find any significant findings with this analyses, future research 
should continue to explore this idea with different samples and studies.  
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Neuroticism and Health Outcomes  
Both samples presented significantly lower mental health scores (43.57 for NZ and 
44.01 for U.S) than average (50). However, both samples provided greater physical health 
scores than average (53.13 for NZ, 52.60 for U.S.). It is possible there may have been some 
participants with particularly low mental health scores which may have attributed to the 
lower than average mean. The New Zealand sample also reported being more physically 
active and had better eating behaviours than the United States sample.  
Mental health was negatively correlated with neuroticism in both studies. Neuroticism 
has been negatively associated with mental health conditions and poorer mental health in 
previous research (Liu & Lin, 2019; Magee et al., 2013). Neuroticism was not significantly 
correlated with physical health in either study. This is in contrast with previous work, as 
neuroticism has been consistently related too poorer health outcomes and been linked to 
several physical health problems (Lahey, 2009). Neuroticism was not significantly correlated 
with BMI in either sample which was in line with the findings from Atherton et al., (2014) 
who found no relationships between neuroticism and health behaviours including BMI. 
Alcohol use and smoking were not correlated with neuroticism in either sample. This 
is in contrast with a lot of previous work that has found those highly neurotic to be more 
likely to indulge in these risky behaviours. Neuroticism has been related to excessive 
drinking (Mroczek et al., 2009; Vollrath & Torgersen, 2002) and smoking (Mroczek et al., 
2009; Shipley et al., 2007). However drug use was positively correlated with neuroticism in 
both samples. This is consistent with previous work which has examined drug use and found 
those higher in neuroticism are more likely to partake in drug use (Vollrath & Torgersen, 
2002). Sleep was negatively correlated with neuroticism in both samples. This is consistent 
with previous work which has found high neuroticism has also been related to poorer sleep 
quality and increased daytime sleepiness (Duggan et al., 2014). 
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Neuroticism was significantly correlated with GP consultations in the New Zealand 
sample but not the United States sample. The New Zealand finding is in support of the 
findings by ten Have et al., (2005) which suggested that those who are highly neurotic are 
more likely to use health services when needed and seek medical attention. However, 
neuroticism was not significantly correlated with GP care seeking in either sample. 
Neuroticism has been consistently linked to riskier health behaviours and in turn, poorer 
health outcomes (Mroczek et al., 2009; Shipley et al., 2007; Vollrath & Torgersen, 2002). 
Eating behaviour was negatively correlated with neuroticism in the New Zealand sample but 
not in the United States. Neuroticism has been found to be related to higher eating disorder 
prevalence (Cervera et al., 2003). Physical activity was negatively correlated with 
neuroticism in the New Zealand sample but not in the United States. Neuroticism has been 
related in previous work to less physical activity (Shipley et al., 2007) and sedentary 
lifestyles (Mroczek et al., 2009).  
Many of the findings were not replicated between Study 1 and Study 2. This suggests 
that what was found, was not overly robust. The New Zealand sample were more neurotic 
with better overall physical health, whereas the United States sample reported a higher 
mental health and sleep rating mean.  Interestingly, the U.S and NZ samples displayed 
opposite mediation and moderation effects with the physical health component and mental 
health component. The New Zealand sample found a mediation effect with physical health 
component and moderation effect with the mental health component, while the United States 
sample found the opposite. It is possible these findings are due to variations in the samples. 
The main difference between the two samples is the mean age and gender difference ratio. 
The mean age for the New Zealand sample was 28.1 years and the mean age for the United 
States sample was older at 38.2 years. The New Zealand sample was 73.8% female whereas 
the United States 53.2% male. However, age and sex were controlled for in all analyses so it 
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will not have influenced the findings. It is possible these differences have influenced the 
differences in correlations however, as these analyses did not control for sex and age.  
Limitations and Strengths 
This research is not without its limitations. Weston and Jackson (2018) highlighted in 
their study that while it can be concluded that neuroticism is related to vigilance, it cannot be 
concluded that neuroticism causes vigilance. This is also a limitation to the present research. 
It cannot be concluded that sensation awareness belief causes higher neuroticism or that 
higher neuroticism causes sensation awareness belief. It can only be concluded that they are 
related. The present research used a cross-sectional design thus the causal pathways cannot 
be examined.  
The present research also relied entirely on self-report measures. Neuroticism has also 
been consistently linked to poorer health outcomes when self-report measures are used 
(Kitayama et al., 2018). It is also possible participants rushed the questionnaire or did not 
answer it entirely truthfully. While attention checks were included, future research could 
incorporate more objective measures (e.g. medical records, further personality testing) in 
order to measure more accurately. This research may have also been limited by the mental 
health scores being lower than average. It is also possible the present research was limited by 
its samples. The New Zealand sample reported better eating and physical activity habits 
however greater alcohol and drug use than the United States sample. It’s possible the 
difference in these scores influenced the overall results of the research and may be 
responsible for the differences between the two samples.  
This research did also have its strengths. Many of the relationships between 
neuroticism and health outcomes were in line with previous research. While few mediation 
effects were found, they do indicate a relationship between neuroticism and body vigilance, 
albeit the relationship was negative. The moderation effects for the New Zealand sample 
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indicated that high levels of conscientiousness can attenuate the negative effect of 
neuroticism slightly, while the United States findings indicate that high levels of neuroticism 
can compensate for low or average levels of conscientiousness.   
Implications and Future Directions 
While the findings of the present research are limited, they provide support to past 
research and suggest pathways for future research. Weston and Jackson’s (2018) key findings 
was that neuroticism was related to better health behaviours through sensation awareness 
belief, was not replicated in the present research. The present findings do support the idea 
that vigilance and neuroticism are related. However, they indicated neuroticism is related to 
higher sensation awareness belief, which in turn, resulted in poorer health outcomes. There is 
currently limited research about the relationship between vigilance and personality factors 
with Weston and Jackson (2018) being, to my knowledge, the first to examine sensation 
awareness belief and change awareness belief. While the present research did not replicate 
their most important findings, they did find that those higher in neuroticism reported higher 
sensation awareness belief, which in turn related to lower self-rated health. This was also 
found in the present research with sensation awareness belief mediating the relationship 
between neuroticism and physical health in the New Zealand sample and mental health in the 
United States sample.  
The moderation findings from the New Zealand sample provide support that high 
neuroticism is related to mental distress. This moderation effect found that high levels of 
conscientiousness can attenuate the negative effect of neuroticism slightly. However, they do 
not provide support to healthy neuroticism. However, the moderation findings from the 
United States sample are exciting. They suggest that high levels of neuroticism can 
compensate for low or average levels of conscientiousness.  This even points to the idea that 
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high levels of neuroticism can benefit your health and even indicates support for healthy 
neuroticism.  
There are many aspects future research should focus on. Firstly, one of the main 
avenues to focus on may be the causal pathways between vigilance and neuroticism in order 
to further understand their relationship. Many neuroticism studies in the past, have used a 
longitudinal design (Mroczek et al., 2009; Najjab et al., 2020; Shipley et al., 2007) and 
measured personality traits at different time points (Magee et al., 2013). Future neuroticism 
and body vigilance research may benefit from this as Weston and Jackson (2018) is the first 
study to examine this relationship. Future body vigilance work could also incorporate 
conscientiousness and other personality measures to assess their influence on vigilance and 
health. Longitudinal studies would allow for more objective measures (to aid in the limitation 
of self-report issues) and to examine how both personality and body vigilance may change in 
the course of one’s life.  
Neuroticism has been found to peak in late adolescence and decline slightly during 
adulthood which is something longitudinal research could also consider (Lahey, 2009). It has 
also been suggested that socio-economic factors, such as social class and education, may lead 
to health risk behaviours that in turn result in worse health, something future research should 
consider (Shipley et al., 2007). These socio-economic factors have also been previously 
related to conscientiousness (Bogg & Roberts, 2004). The impact of neuroticism on 
wellbeing has also been found largely indirect via psychological and physical health issues, 
something longitudinal research may also be able to consider (Gale et al., 2013). Most 
importantly, a longitudinal study would allow for the causal pathways to be explored which 
may be key in understanding the relationship between neuroticism and vigilance. Friedman 
(2019) presented the idea that neuroticism can lead people down two paths. The first is a 
pessimistic and anxious path that causes people to turn to unhealthy or risky behaviours and 
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the second path is one in which neuroticism results in vigilance and body awareness which in 
turn results in better health. This theory may influence or help explain the causal pathways 
that lead to healthy neuroticism and should be considered in future work.  
Future studies may benefit by assessing the prevalence of any mental illness, physical 
illness or distress. Many studies include a measure of chronic conditions, both mental and 
physical (Liu & Lin, 2019; Najjab et al., 2020; Weston & Jackson, 2018). A longitudinal 
study would allow not only for this to be measured, but also its course and relationship with 
personality factors and body vigilance. Neuroticism has also been linked to higher mortality 
(Shipley et al., 2007) something a longitudinal study could also measure. Future research 
could also include samples with varying and similar health outcome scores and demographic 
information in order to examine differences. 
While this research did not find overwhelming support for healthy neuroticism, the 
theory should not be discarded. This is only the second study, to my knowledge, that 
examines Weston and Jackson’s (2018) body vigilance measures and conscientiousness. 
Healthy neuroticism has been increasingly discussed in literature since Friedman (2000) first 
presented it and should continue to be explored including both body vigilance and 
conscientiousness. While many studies still find negative effects of neuroticism on health 
outcomes, future research should continue to examine the links between both neuroticism and 
body vigilance and neuroticism and conscientiousness.  
Conclusions 
Overall, the findings from the present research partially supported my hypotheses. 
This research only produced minimal mediation and moderation effects. The aim of these 
studies was to replicate the findings found in Study 1 and 2. While it is disappointing that the 
present research did not replicate results across Study 1 and 2, it is interesting to note the 
findings similarities to other research.   This research also aimed to explore the idea of 
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healthy neuroticism. While it is disappointing that this research only found one moderation 
effect that indicates high neuroticism and high conscientiousness may interact in a protective 
manner, it is still worth exploring and expanding on in future research. It is clear that more 
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Appendix A 
INFORMATION SHEET 1 – For United States Participants on MTurk 
Personality and health behaviour Information Sheet  
Thank you for your interest in this study. I am a Master’s student from the School of 
Psychology, Speech and Hearing, University of Canterbury in New Zealand and we are 
looking for participants to complete an anonymous survey on personality and health 
behaviour.  
What does participation involve?  
Participation involves completing an online survey that will take around 20 minutes to 
complete. In this survey we will ask you questions about your personality and your health 
behaviours (such as eating behaviour and food intake, exercise, smoking)  
Is there a reward for participation?  
Each participant will receive US $2.00 following completion of the questionnaire. The 
questionnaire must be completed in full and all participant codes must be entered correctly 
into the survey and into Mechanical Turk in order to receive payment.  
 
Who can participate?  
Anyone who is over 18 and fluent in English can complete the study. If you do not fulfil 
these criteria, please exit the survey now.  
 
What happens to the information I provide?  
The results of the study may be published, but you may be assured of the complete 
confidentiality of the data gathered in this study. We will not ask for any identifying 
information in the questionnaire. Data will be stored in a secure office in the Department of 
Psychology at the University of Canterbury. Only the researchers will have access to the data. 
The data will be stored securely for 5 years following the completion of the project and will 
then be destroyed.  
 
Participation is voluntary and you have the right to withdraw without penalty. If you start the 
questionnaire and decide that you do not want to continue, please exit the questionnaire. Your 
incomplete questionnaire will then be withdrawn from the data base. However, once you 
have electronically submitted the questionnaire your data can no longer be removed.  
 
Are there any risks involved?  
The questionnaire has been reviewed and approved by the University of Canterbury Human 
Ethics Committee, and participants should address any complaints to The Chair, Human 
NEUROTICISM AND HEALTH OUTCOMES 56 
Ethics Committee, University of Canterbury, Private Bag 4800, Christchurch, New Zealand 
(human-ethics@canterbury.ac.nz). Participation is voluntary and all data will be anonymous.  
It is not anticipated that participation in this study will pose any risk. If at any point you do 
not wish to continue your participation in the study, simply exit the survey and your 
responses will not be recorded. If you experience any concern about health issues, experience 
any emotional distress or you would like advice on how to change a health behaviour (such 
as eating healthier or quitting smoking), please contact your Family Physician for advice. 
Unfortunately we are unable to reimburse you for any related costs.  
There are also several online resources that you may like to use:  
USDA Center for Nutrition Policy and Promotion: https://www.choosemyplate.gov/myplate-
tip- sheets  
The American Heart Association: https://www.heart.org/en/healthy-living  
Tools and Tips to Quit smoking: https://smokefree.gov/  
 
Who are the researchers?  
This research is carried out by Meg Elston as part of a Master’s Thesis. She can be contacted 
at meg.elston@pg.canterbury.ac.nz. She is under the supervision of Associate Professor 
Roeline Kuijer who works at the Department of Psychology at the University of Canterbury. 
She can be contacted at roeline.kuijer@canterbury.ac.nz. They will be pleased to discuss any 
questions or concerns you might have about participation in the project. 
 
Consent  
I have read and understood the description of the above-named study. On this basis I agree to 
participate, and I consent to publication of the results of this study with the understanding 
that confidentiality will be preserved. I understand that my participation is entirely 
anonymous and that I may withdraw from the study at any point before I submit my 
responses.  
O I agree to participate (please go to the next page to start the questionnaire) 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INFORMATION SHEET 2 – For Social Media Participants 
Personality and health behaviour Information Sheet  
Thank you for your interest in this study. I am a Master’s student from the School of 
Psychology, Speech and Hearing, University of Canterbury and we are looking for 
participants to complete an anonymous survey on personality and health behaviour.  
 
What does participation involve?  
Participation involves completing an online survey that will take around 20 minutes to 
complete. In this survey we will ask you questions about your personality your health 
behaviours (such as eating behaviour and food intake, exercise, smoking)  
 
Is there a reward for participation?  
Each participant who is entered via social media has the option entered into the draw to 
receive one of 4x $50 gift vouchers. The prize draw is optional.  
Who can participate?  
Anyone recruited via social media, who is over 18 and fluent in English can complete the 
study. If you do not fulfil these criteria, please exit the survey now.  
What happens to the information I provide?  
The results of the study may be published, but you may be assured of the complete 
confidentiality of the data gathered in this study. We will not ask for any identifying 
information in the questionnaire. Data will be stored in a secure office in the Department of 
Psychology at the University of Canterbury. Only the researchers will have access to the data. 
The data will be stored securely for 5 years following the completion of the project and will 
then be destroyed.  
Participation is voluntary and you have the right to withdraw without penalty. If you start the 
questionnaire and decide that you do not want to continue, please exit the questionnaire. Your 
incomplete questionnaire will then be withdrawn from the data base. However, once you 
have electronically submitted the questionnaire your data can no longer be removed.  
Are there any risks involved?  
The questionnaire has been reviewed and approved by the University of Canterbury Human 
Ethics Committee, and participants should address any complaints to The Chair, Human 
Ethics Committee, University of Canterbury, Private Bag 4800, Christchurch, New Zealand 
(human-ethics@canterbury.ac.nz). Participation is voluntary and all data will be anonymous.  
It is not anticipated that participation in this study will pose any risk. If at any point you do 
not wish to continue your participation in the study, simply exit the survey and your 
responses will not be recorded. If you experience any concern about health issues, experience 
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any emotional distress or you would like advice on how to change a health behaviour (such 
as eating healthier or quitting smoking), please contact your General Practitioner for advice.  
There are also several resources that you may like to use:  
Healthline: 0800 611 116 
 
Lifeline: 0800 543 354, https://www.lifeline.org.nz/ 
 
Youthline: 0800 376 633, https://www.youthline.co.nz/ 
 
Who are the researchers?  
This research is carried out by Meg Elston as part of a Master’s Thesis. She can be contacted 
at meg.elston@pg.canterbury.ac.nz. She is under the supervision of Associate Professor 
Roeline Kuijer who works at the Department of Psychology at the University of Canterbury. 
She can be contacted at roeline.kuijer@canterbury.ac.nz. They will be pleased to discuss any 
questions or concerns you might have about participation in the project. 
Consent  
I have read and understood the description of the above-named study. On this basis I agree to 
participate, and I consent to publication of the results of this study with the understanding 
that confidentiality will be preserved. I understand that my participation is entirely 
anonymous and that I may withdraw from the study at any point before I submit my 
responses.  
 
O I agree to participate (please go to the next page to start the questionnaire) 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INFORMATION SHEET 3 – For University of Canterbury Psychology Students  
Personality and health behaviour Information Sheet  
Thank you for your interest in this study. I am a Master’s student from the School of 
Psychology, Speech and Hearing, University of Canterbury and we are looking for 
participants to complete an confidential survey on personality and health behaviour.  
 
What does participation involve?  
Participation involves completing an online survey that will take around 20 minutes to 
complete. In this survey we will ask you questions about your personality and your health 
behaviours (such as eating behaviour and food intake, exercise, smoking)  
 
Is there a reward for participation?  
Each participant who is entered via the PSYC106 participant pool will receive 1 course credit 
for PSYC106 following completion of the questionnaire.  
Who can participate?  
Anyone, who is over 18 and fluent in English can complete the study. If you do not fulfil 
these criteria, please exit the survey now.  
What happens to the information I provide?  
The results of the study may be published, but you may be assured of the complete 
confidentiality of the data gathered in this study. The identity of each participant is 
confidential to the researcher, and all data will be anonymised prior to publication. We will 
not ask for any identifying information in the questionnaire. Data will be stored in a secure 
office in the Department of Psychology at the University of Canterbury. Only the researchers 
will have access to the data. The data will be stored securely for 5 years following the 
completion of the project and will then be destroyed.  
Participation is voluntary and you have the right to withdraw without penalty. If you start the 
questionnaire and decide that you do not want to continue, please exit the questionnaire. Your 
incomplete questionnaire will then be withdrawn from the data base. If you later do you want 
to have your data included, please contact Meg Elston (meg.elston@pg.canterbury.ac.nz) up 
until November 1st to have your data removed.  
Are there any risks involved?  
The questionnaire has been reviewed and approved by the University of Canterbury Human 
Ethics Committee, and participants should address any complaints to The Chair, Human 
Ethics Committee, University of Canterbury, Private Bag 4800, Christchurch, New Zealand 
(human-ethics@canterbury.ac.nz). Participation is voluntary and all data will be confidential.  
It is not anticipated that participation in this study will pose any risk. If at any point you do 
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not wish to continue your participation in the study, simply exit the survey and your 
responses will not be recorded. If you experience any concern about health issues, experience 
any emotional distress or you would like advice on how to change a health behaviour (such 
as eating healthier or quitting smoking), please contact your General Practitioner for advice.  
There are also several resources that you may like to use:  
Healthline: 0800 611 116 
 
Lifeline: 0800 543 354, https://www.lifeline.org.nz/ 
 
Youthline: 0800 376 633, https://www.youthline.co.nz/ 
 
Who are the researchers?  
This research is carried out by Meg Elston as part of a Master’s Thesis. She can be contacted 
at meg.elston@pg.canterbury.ac.nz. She is under the supervision of Associate Professor 
Roeline Kuijer who works at the Department of Psychology at the University of Canterbury. 
She can be contacted at roeline.kuijer@canterbury.ac.nz. They will be pleased to discuss any 
questions or concerns you might have about participation in the project. 
Consent  
I have read and understood the description of the above-named study. On this basis I agree to 
participate, and I consent to publication of the results of this study with the understanding 
that confidentiality will be preserved. I understand that my participation is entirely 
anonymous and that I may withdraw from the study at any point before I submit my 
responses.  
 
O I agree to participate (please go to the next page to start the questionnaire) 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Appendix B 
HUMAN ETHICS COMMITTEE  
Secretary, Rebecca Robinson  
Telephone: +64 03 369 4588, Extn 94588  
Email: human-ethics@canterbury.ac.nz  
Ref: HEC 2019/71 22 July 2019  
Meg Elston 
Psychology, Speech and Hearing UNIVERSITY OF CANTERBURY  
Dear Meg  
The Human Ethics Committee advises that your research proposal “What Makes Healthy 
Neuroticism? Neuroticism, Vigilance and Conscientiousness” has been considered and 
approved.  
Please note that this approval is subject to the incorporation of the amendments you have 
provided in your email of 12th July 2019.  
Best wishes for your project. Yours sincerely  
Dr Dean Sutherland  
Chair 
University of Canterbury Human Ethics Committee  
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Appendix C 
GP Consultations (for New Zealand) Family Physician Consultation (for United States).  
On average, how often do you visit your GP? 
1. Less than once a year 
2. Once a year 
3. Twice a year 
4. At least every couple of months 
You’ve had a runny nose for 2 days now, how likely are you to go to the doctor? 
1. Definitely go  
2. Probably go 
3. Probably won’t go 
4. Definitely won’t go  
You’ve had sharp pain for over a week now, how likely are you to go to the doctor? 
1. Definitely go  
2. Probably go 
3. Probably won’t go 
4. Definitely won’t go  
 
Height and Weight  
Please answer the following questions as accurately as possible. If you do not know and are 
unable to measure yourself, please answer with your best estimate.  
What is your height? (in centimetres for New Zealand sample, inches for United States 
sample) _______________________________________________________  
What is your weight? (in Kgs for PYSC106 and social media, pounds for 
MTurk)_______________________________________________________ 
Just so that we know: how accurate are your estimates of your self-reported weight and 
height?  
1. Both pretty accurate  
2. Height pretty accurate, but I guessed my weight  
3. Definitely won’t go  
4. I guessed both 
 
Health Risk Behaviours: 
Eating Behaviour  
 
The following questions ask about your eating pattern. In the PAST TWO WEEKS, on how 




on 5 or 6 
days/week  
on 3 or 4 
days/week  






eat healthy amounts of food 
(not too much or too little)  
O O O O O 
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eat in a balanced way with a 
lot of fruit and vegetables  
O O O O O 
eat junk food (eg, potato chips, 
desserts, sweets, chocolate etc)   
O O O O O 
overeat (kept eating while you 
were already full)  
O O O O O 
eat breakfast  O O O O O 
eat fast food (eg, fish and 
chips, McDonalds, meat pies, 
KFC etc)   
O O O O O 
 
 
All things considered: How healthy has your eating been over the PAST 2 WEEKS? 
 
 Not very healthy      Very healthy 
  1 2 3 4 5 6 7  
 
 
Physical Activity  
The following questions are about the time you spent being physically active. By 'active' we 
mean doing anything using your muscles. Think about activities at work, school or home, 
getting from place to place, and any activities you did for exercise, sport, recreation or 
leisure. 
  
1. During the last 7 days, on how many days did you get 30+ minutes of moderate physical 
activity? Moderate activities make you breathe harder than normal, but only a little, like 
carrying light loads, brisk walking, or bicycling at a regular pace, 
O 0 days   
O 1 day  
O 2 days  
O 3 days   
O 4 days  
O 5 days  
O 6 days  
O 7 days   
 
2. During the last 7 days, on how many days did you get 20+ minutes of vigorous physical 
activity? Vigorous activities make you breathe a lot harder than normal ("huff and puff") - 
like heavy lifting, digging, aerobics, fast bicycling   
O 0 days   
NEUROTICISM AND HEALTH OUTCOMES 64 
O 1 day  
O 2 days  
O 3 days   
O 4 days  
O 5 days  
O 6 days  
O 7 days   
 
3. This question is about the time you spent sitting on weekdays during the last 7 days. 
Include time spent at work, at home, while doing course work and during leisure time. This 
may include time spent sitting at a desk, visiting friends, reading, or sitting or lying down to 
watch television.  During the last 7 days, how much time did you spend sitting on a week 
day? 
O 1-2 hours   
O 3-4 hours   
O 5-6 hours   
O 7-8 hours   
O 9-10 hours 
O 11-12 hours   
O 13-14 hours   





1. Do you smoke? 
O Yes  
O No, I am an ex-smoker 
O No, I never smoked  
 
1a. How many cigarettes do you smoke on a typical day? 
O Less than 1 per day  
O 1 - 5 per day  
O 6 - 10 per day  
O 11 - 15 per day   
O 16 - 20 per day   
O 21 - 25 per day 
O 26 - 30 per day  
O 31+ a day  
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Alcohol Use 
 
2. How often do you have a drink containing alcohol? 
O Never, I don't drink alcohol  
O Once a month or less  
O Up to 4 times a month   
O On 2-3 days a week   
O On 4-5 days a week   
O On 6-7 days a week   
 
2a. How many standard drinks containing alcohol do you have on a typical day when you are 
drinking?  (see picture below) 
O 1 or 2   
O 3 or 4   
O 5 or 6    
O 7 or 8    
O 9 or 10  




2b. How often do you have six or more standard drinks on one occasion? (see picture above) 
O Never   
O Less than monthly  
O Monthly  
O Weekly   
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Drug Use 
 
How many times in the past month have you used illicit drugs? 
- Haven’t used  
- Once 
- 2-3 times 
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Appendix D 
Vigilance Questionnaire 
Sensation Awareness Belief 
These items are measured with a likert scale: 
1 (never) 2 (sometimes) 3 (regularly) 4 (often) 5 (always)  
How much do you wonder about why your body feels the way it does?   
How much do you think about how your body feels?   
How much do you try to figure out how your body works?  
How much do you notice changes in how your body feels?   
On average, how much time do you spend scanning your body for sensations?   
These items are measured on a likert scale: 
1 (strongly disagree) 2 (disagree) 3 (neither agree nor disagree) 4 (agree) 5 (strongly agree) 
I am very sensitive to changes in my internal bodily sensations.  
I am the kind of person who pays close attention to internal bodily sensations.   
It is important for me to know how my body is feeling throughout the day.   
I am sensitive to internal bodily tensions.  
My mind and my body often want to do different things.  
I can often feel my heart beating.   
I notice differences in the way my body reacts to various foods.   
I enjoy becoming aware of how my body feels.  
I notice specific body responses to changes in the weather.  
My bodily desires lead me to do things that I end up regretting.  
I am quick to sense the hunger contractions of my stomach.   
I suppress my bodily feelings and sensations.  
Change Awareness Belief  
I can accurately predict what time of day lack of sleep will catch up with me. 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I am aware of a cycle in my activity level throughout the day.  
I can predict how much sleep I will need at night in order to wake up refreshed.  
I can distinguish between tiredness because of hunger and because of lack of sleep. 
As soon as I wake up I know how much energy I’ll have during the day. 
When my exercise habits change, I can predict how that will affect my energy level.  
I can always tell when I bump myself whether or not it will become a bruise.  
I can tell when I go to bed how I will sleep that night.  
I know in advance when I’m getting the flu.  
I know I’m running a fever without taking my temperature.   
There seems to be a best time for me to go to sleep at night.  
I notice specific bodily reactions to being overhungry.  
I am always aware of changes in my energy level when I eat certain foods.  
I notice distinct body reactions when I am fatigued.  
I always know when I’ve exerted myself to the point where I’ll be sore the next day.  
I am very aware of changes in my body temperature. 
I know immediately when my mouth or throat gets dry.  
I don’t notice seasonal rhythms and cycles in the way my body functions.  
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Appendix E 
Full Correlation Table for New Zealand Sample. 
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Appendix F 
Full Correlation Table for United States Sample.  
 
 
